GCIA
LXRX icon

Gabelli & Co Investment Advisers’s Lexicon Pharmaceuticals LXRX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,143
Closed -$21K – 165
2014
Q3 		$21K Hold
2,143
– – ﹤0.01% 171
2014
Q2 		$24K Hold
2,143
– – 0.01% 134
2014
Q1 		$26K Hold
2,143
– – 0.01% 124
2013
Q4 		$27K Hold
2,143
– – 0.01% 119
2013
Q3 		$36K Hold
2,143
– – 0.01% 126
2013
Q2 		$33K Buy
+2,143
New +$32.6K 0.01% 123

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gabelli & Co Investment Advisers's LXRX Position: Q4 2014 in Review

Gabelli & Co Investment Advisers sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2014, closing a stake of 2,143 shares — an estimated $21K sold.

Gabelli & Co Investment Advisers first reported a position in LXRX in Q2 2013 and held it in 6 quarters. The position peaked at $36K in Q3 2013. 123 funds tracked by Wall St. Rank hold LXRX as of Q4 2014.

  • Gabelli & Co Investment Advisers reported no remaining Lexicon Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 2,143 Lexicon Pharmaceuticals shares in Q4 2014, an estimated $21K.
  • Gabelli & Co Investment Advisers first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Gabelli & Co Investment Advisers's Lexicon Pharmaceuticals position peaked at $36K in Q3 2013.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2014.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2014, filed 5 Feb 2015.